Patients with psoriasis have a high prevalence of cardiovascular risk factors; as such, an increased risk for cardiovascular disease is not unexpected. However, international studies have shown that psoriasis is associated with an increased risk for myocardial infarction independent of such factors as body mass index, smoking, hypertension, diabetes, and dyslipidemia. In addition, more severe disease is associated with more clinically significant risk.
The incidence of mood disorders, such as depression, anxiety, and suicidal ideation, is increased among patients with psoriasis.
Patients who received psoralen and ultraviolet A phototherapy for their psoriasis have a markedly increased risk for skin cancer.
Unfortunately, the arthritic changes associated with PsA cannot be reversed, highlighting the importance of prompt treatment initiation among patients with psoriasis.
For additional information, refer to the 2020 British Association of Dermatologists guidelines for biologic therapy for psoriasis and the joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with biologics.
Learn more about treatment options for psoriasis.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: William James. Fast Five Quiz: Psoriasis Comorbidities - Medscape - Dec 17, 2021.